Optimizing the use of nirmatrelvir/ritonavir in solid organ transplant recipients with COVID-19: A review of immunosuppressant adjustment strategies

The coronavirus disease 2019 (COVID-19) pandemic has caused a significant burden of morbidity and mortality worldwide, with solid organ transplant recipients (SOTRs) being particularly vulnerable. Nirmatrelvir and ritonavir have demonstrated the potential for reducing the risk of hospitalization and...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Yangming, Li, Yue, Song, Turun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111375/
https://www.ncbi.nlm.nih.gov/pubmed/37081880
http://dx.doi.org/10.3389/fimmu.2023.1150341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111375/
https://www.ncbi.nlm.nih.gov/pubmed/37081880
http://dx.doi.org/10.3389/fimmu.2023.1150341

Ejemplares similares